Renovaro, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29350E1047
USD
1.30
0.04 (3.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryRenovaro, Inc. VS Pharmaceuticals & Biotechnology
 
1D
3.17%
0.3%
1W
0.78%
0.54%
1M
49.27%
-0.03%
YTD
-84.44%
16.46%
1Y
-87.5%
13.22%
3Y
9.24%
68.23%
5Y
-95.5%
86.81%
10Y
-95.5%
234.19%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-41.57%
0%
-41.57%
6 Months
-54.86%
0%
-54.86%
1 Year
-87.5%
0%
-87.5%
2 Years
-96.07%
0%
-96.07%
3 Years
9.24%
0%
9.24%
4 Years
-98.61%
0%
-98.61%
5 Years
-95.5%
0%
-95.5%

Renovaro, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary